El-Serag HB: Hepatocellular carcinoma. N Engl J Med. 2011, 365: 1118-1127. 10.1056/NEJMra1001683.
Article
CAS
PubMed
Google Scholar
Farazi PA, DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006, 6: 674-687. 10.1038/nrc1934.
Article
CAS
PubMed
Google Scholar
Li Y, Tang ZY, Hou JX: Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol. 2012, 9: 32-43.
Article
Google Scholar
Tao Y, Ruan J, Yeh SH, Lu X, Wang Y, Zhai W, Cai J, Ling S, Gong Q, Chong Z, Qu Z, Li Q, Liu J, Yang J, Zheng C, Zeng C, Wang HY, Zhang J, Wang SH, Hao L, Dong L, Li W, Sun M, Zou W, Yu C, Li C, Liu G, Jiang L, Xu J, Huang H: Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A. 2011, 108: 12042-12047. 10.1073/pnas.1108715108.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gerlinger M, Swanton C: How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer. 2010, 103: 1139-1143. 10.1038/sj.bjc.6605912.
Article
PubMed Central
CAS
PubMed
Google Scholar
Luo J, Solimini NL, Elledge SJ: Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009, 136: 823-837. 10.1016/j.cell.2009.02.024.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brock A, Chang H, Huang S: Non-genetic heterogeneity a mutation-independent driving force for the somatic evolution of tumours. Nat Rev Genet. 2009, 10: 336-342. 10.1038/nrg2556.
Article
CAS
PubMed
Google Scholar
Marusyk A, Almendro V, Polyak K: Intra-tumour heterogeneity: a looking glass for cancer?. Nat Rev Cancer. 2012, 12: 323-334.
Article
CAS
PubMed
Google Scholar
Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Pierre Martinez P, Matthews N, Stewart A: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012, 366: 883-892. 10.1056/NEJMoa1113205.
Article
CAS
PubMed
Google Scholar
Lee AJ, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ, Futreal PA, Downward J, Szallasi Z, Tomlinson IP, Howell M, Kschischo M, Swanton C: Chromosomal instability confers intrinsic multidrug resistance. Cancer Res. 2011, 71: 1858-1870. 10.1158/0008-5472.CAN-10-3604.
Article
PubMed Central
CAS
PubMed
Google Scholar
Egeblad M, Nakasone ES, Werb Z: Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010, 18: 884-901. 10.1016/j.devcel.2010.05.012.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bissell MJ, Kenny PA, Radisky DC: Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol. 2005, 70: 343-356. 10.1101/sqb.2005.70.013.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tlsty TD, Coussens LM: Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2006, 1: 119-150. 10.1146/annurev.pathol.1.110304.100224.
Article
CAS
PubMed
Google Scholar
Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F, Travali S, Spandidos DA, Libra M: The tumour microenvironment in hepatocellular carcinoma. Int J Oncol. 2012, 40: 1733-1747.
CAS
PubMed
Google Scholar
Wu SD, Ma YS, Fang Y, Liu LL, Fu D, Shen XZ: Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev. 2012, 38: 218-225. 10.1016/j.ctrv.2011.06.010.
Article
CAS
PubMed
Google Scholar
Mikula M, Proell V, Fischer AN, Mikulits W: Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion. J Cell Physiol. 2006, 209: 560-567. 10.1002/jcp.20772.
Article
PubMed Central
CAS
PubMed
Google Scholar
Coulouarn C, Corlu A, Glaise D, Guénon I, Thorgeirsson SS, Clément B: Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res. 2012, 72: 2533-2542. 10.1158/0008-5472.CAN-11-3317.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhao W, Zhang L, Yin Z, Su W, Ren G, Zhou C, You J, Fan J, Wang X: Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Int J Cancer. 2011, 129: 2651-2661. 10.1002/ijc.25920.
Article
CAS
PubMed
Google Scholar
Sancho-Bru P, Juez E, Moreno M, Khurdayan V, Morales-Ruiz M, Colmenero J, Arroyo V, Brenner DA, Ginès P, Bataller R: Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells. Liver Int. 2010, 30: 31-41. 10.1111/j.1478-3231.2009.02161.x.
Article
CAS
PubMed
Google Scholar
Faouzi S, Lepreux S, Bedin C, Dubuisson L, Balabaud C, Bioulac-Sage P, Desmoulière A, Rosenbaum J: Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest. 1999, 79: 485-493.
CAS
PubMed
Google Scholar
Xia Y, Chen R, Song Z, Ye S, Sun R, Xue Q, Zhang Z: Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum. J Cancer Res Clin Oncol. 2010, 136: 309-321. 10.1007/s00432-009-0666-5.
Article
CAS
PubMed
Google Scholar
Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E, Rizzo MM, Rodriguez A, Lorenti A, Andriani O, Podhajcer O, Mazzolini G: Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Mol Pharm. 2011, 8: 1538-1548. 10.1021/mp200137c.
Article
CAS
PubMed
Google Scholar
Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N: Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2005, 102: 3389-3394. 10.1073/pnas.0409722102.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hou X, Kumar A, Lee C, Wang B, Arjunan P, Dong L, Maminishkis A, Tang Z, Li Y, Zhang F, Zhang SZ, Wardega P, Chakrabarty S, Liu B, Wu Z, Colosi P, Fariss RN, Lennartsson J, Nussenblatt R, Gutkind JS, Cao Y, Li X: PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets. Proc Natl Acad Sci U S A. 2010, 107: 12216-12221. 10.1073/pnas.1004143107.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nevzorova YA, Hu W, Cubero FJ, Haas U, Freimuth J, Tacke F, Trautwein C, Liedtke C: Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis. Biochim Biophys Acta. 1832, 2013: 1765-1775.
Google Scholar
van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, Eferl R, Beug H, Dolznig H, Mikulits W: Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene. 2009, 28: 4022-4033. 10.1038/onc.2009.253.
Article
PubMed Central
CAS
PubMed
Google Scholar
Taura K, De Minicis S, Seki E, Hatano E, Iwaisako K, Osterreicher CH, Kodama Y, Miura K, Ikai I, Uemoto S, Brenner DA: Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology. 2008, 135: 1729-1738. 10.1053/j.gastro.2008.07.065.
Article
CAS
PubMed
Google Scholar
Campbell JS, Johnson MM, Bauer RL, Hudkins KL, Gilbertson DG, Riehle KJ, Yeh MM, Alpers CE, Fausto N: Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis. Differentiation. 2007, 75: 843-852. 10.1111/j.1432-0436.2007.00235.x.
Article
CAS
PubMed
Google Scholar
Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000, 1: 31-39. 10.1038/35036052.
Article
CAS
PubMed
Google Scholar
Gao X, Lowry PR, Zhou X, Depry C, Wei Z, Wong GW, Zhang J: PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc Natl Acad Sci U S A. 2011, 108: 14509-14514. 10.1073/pnas.1019386108.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-Madrid F: Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol. 2009, 19: 434-446. 10.1016/j.tcb.2009.06.004.
Article
PubMed
Google Scholar
Mazzocca A, Carloni V, Sciammetta S, Cordella C, Pantaleo P, Caldini A, Gentilini P, Pinzani M: Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. J Hepatol. 2002, 37: 322-330. 10.1016/S0168-8278(02)00175-7.
Article
CAS
PubMed
Google Scholar
Zoller M: Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer. 2009, 9: 40-55. 10.1038/nrc2543.
Article
PubMed
Google Scholar
Oren R, Takahashi S, Doss C, Levy R, Levy S: TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol. 1990, 10: 4007-4015.
Article
PubMed Central
CAS
PubMed
Google Scholar
Carloni V, Mazzocca A, Ravichandran KS: Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells. Oncogene. 2004, 23: 1566-1574. 10.1038/sj.onc.1207287.
Article
CAS
PubMed
Google Scholar
Mukherjee S, Maxfield FR: Membrane domains. Annu Rev Cell Dev Biol. 2004, 20: 839-866. 10.1146/annurev.cellbio.20.010403.095451.
Article
CAS
PubMed
Google Scholar
Inoue G, Horiike N, Onji M: The CD81 expression in liver in hepatocellular carcinoma. Int J Mol Med. 2001, 7: 67-71.
CAS
PubMed
Google Scholar
Schöniger-Hekele M, Hänel S, Wrba F, Müller C: Hepatocellular carcinoma–survival and clinical characteristics in relation to various histologic molecular markers in Western patients. Liver Int. 2005, 25: 62-69. 10.1111/j.1478-3231.2004.0997.x.
Article
PubMed
Google Scholar
Mazzocca A, Liotta F, Carloni V: Tetraspanin CD81-regulated cell motility plays a critical role in intrahepatic metastasis of hepatocellular carcinoma. Gastroenterology. 2008, 135: 244-256. 10.1053/j.gastro.2008.03.024.
Article
CAS
PubMed
Google Scholar
Chiang AC, Massague J: Molecular basis of metastasis. N Engl J Med. 2008, 359: 2814-2823. 10.1056/NEJMra0805239.
Article
PubMed Central
CAS
PubMed
Google Scholar
Testa JE, Brooks PC, Lin JM, Quigley JP: Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res. 1999, 59: 3812-3820.
CAS
PubMed
Google Scholar
Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, Ding ZB, Wang XY, Devbhandari RP, Fan J: CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial–mesenchymal transition in HCC cells. Gastroenterology. 2011, 140: 1629-1641. 10.1053/j.gastro.2011.02.008.
Article
CAS
PubMed
Google Scholar
Gesierich S, Berezovskiy I, Ryschich E, Zoller M: Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res. 2006, 66: 7083-7094. 10.1158/0008-5472.CAN-06-0391.
Article
CAS
PubMed
Google Scholar
Kanetaka K, Sakamoto M, Yamamoto Y, Takamura M, Kanematsu T, Hirohashi S: Possible involvement of tetraspanin CO-029 in hematogenous intrahepatic metastasis of liver cancer cells. J Gastroenterol Hepatol. 2003, 18: 1309-1314. 10.1046/j.1440-1746.2003.03182.x.
Article
CAS
PubMed
Google Scholar
Guo XZ, Friess H, Di Mola FF, Heinicke JM, Abou-Shady M, Graber HU, Baer HU, Zimmermann A, Korc M, Büchler MW: KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology. 1998, 28: 1481-1488. 10.1002/hep.510280606.
Article
CAS
PubMed
Google Scholar
Guo W, Giancotti FG: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004, 5: 816-826. 10.1038/nrm1490.
Article
CAS
PubMed
Google Scholar
Begum NA, Mori M, Matsumata T, Takenaka K, Sugimachi K, Barnard GF: Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma. Hepatology. 1995, 22: 1447-1455.
Article
CAS
PubMed
Google Scholar
Torimura T, Ueno T, Kin M, Inuzuka S, Sugawara H, Tamaki S, Tsuji R, Sujaku K, Sata M, Tanikawa K: Coordinated expression of integrin alpha6beta1 and laminin in hepatocellular carcinoma. Hum Pathol. 1997, 28: 1131-1138. 10.1016/S0046-8177(97)90250-1.
Article
CAS
PubMed
Google Scholar
Wewer UM, Shaw LM, Albrechtsen R, Mercurio AM: The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. Am J Pathol. 1997, 151: 1191-1198.
PubMed Central
CAS
PubMed
Google Scholar
Nejjari M, Hafdi Z, Dumortier J, Bringuier AF, Feldmann G, Scoazec JY: alpha6beta1 integrin expression in hepatocarcinoma cells: regulation and role in cell adhesion and migration. Int J Cancer. 1999, 83: 518-525. 10.1002/(SICI)1097-0215(19991112)83:4<518::AID-IJC14>3.0.CO;2-Q.
Article
CAS
PubMed
Google Scholar
Carloni V, Romanelli RG, Mercurio AM, Pinzani M, Laffi G, Cotrozzi G, Gentilini P: Knockout of alpha6 beta1-integrin expression reverses the transformed phenotype of hepatocarcinoma cells. Gastroenterology. 1998, 115: 433-442. 10.1016/S0016-5085(98)70210-0.
Article
CAS
PubMed
Google Scholar
Carloni V, Mazzocca A, Pantaleo P, Cordella C, Laffi G, Gentilini P: The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells. Hepatology. 2001, 34: 42-49.
Article
CAS
PubMed
Google Scholar
Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S: Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology. 2005, 129: 1375-1383. 10.1053/j.gastro.2005.09.055.
Article
CAS
PubMed
Google Scholar
Radisky DC, Bissell MJ: Matrix metalloproteinase-induced genomic instability. Curr Opin Genet Dev. 2006, 16: 45-50. 10.1016/j.gde.2005.12.011.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J: Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008, 359: 1995-2004. 10.1056/NEJMoa0804525.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kohga K, Takehara T, Tatsumi T, Miyagi T, Ishida H, Ohkawa K, Kanto T, Hiramatsu N, Hayashi N: Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Res. 2009, 69: 8050-8057. 10.1158/0008-5472.CAN-09-0789.
Article
CAS
PubMed
Google Scholar
Yang CL, Jiang FQ, Xu F, Jiang GX: ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma. Tumour Biol. 2012, 33: 1535-1541. 10.1007/s13277-012-0405-4.
Article
CAS
PubMed
Google Scholar